CN103463445A - 一种治疗肿胀型前庭大腺炎的中药洗剂制备方法 - Google Patents
一种治疗肿胀型前庭大腺炎的中药洗剂制备方法 Download PDFInfo
- Publication number
- CN103463445A CN103463445A CN201310458861XA CN201310458861A CN103463445A CN 103463445 A CN103463445 A CN 103463445A CN 201310458861X A CN201310458861X A CN 201310458861XA CN 201310458861 A CN201310458861 A CN 201310458861A CN 103463445 A CN103463445 A CN 103463445A
- Authority
- CN
- China
- Prior art keywords
- grams
- herba
- radix
- chinese medicine
- swelling type
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000008961 swelling Effects 0.000 title claims abstract description 45
- 239000003814 drug Substances 0.000 title claims abstract description 37
- 206010004142 Bartholinitis Diseases 0.000 title claims abstract description 22
- 239000006210 lotion Substances 0.000 title claims abstract description 11
- 238000000034 method Methods 0.000 title abstract description 8
- 238000011282 treatment Methods 0.000 claims abstract description 19
- 239000007788 liquid Substances 0.000 claims abstract description 10
- 241000746375 Andrographis Species 0.000 claims abstract description 7
- 210000003608 fece Anatomy 0.000 claims abstract description 7
- 206010042674 Swelling Diseases 0.000 claims description 41
- 239000000796 flavoring agent Substances 0.000 claims description 7
- 235000019634 flavors Nutrition 0.000 claims description 7
- 210000000582 semen Anatomy 0.000 claims description 7
- 241000756943 Codonopsis Species 0.000 claims description 6
- 241000628997 Flos Species 0.000 claims description 6
- 241001250596 Pleione Species 0.000 claims description 6
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 5
- 229940126678 chinese medicines Drugs 0.000 claims description 3
- 239000003643 water by type Substances 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 11
- 231100000331 toxic Toxicity 0.000 abstract description 5
- 230000002588 toxic effect Effects 0.000 abstract description 5
- 235000008216 herbs Nutrition 0.000 abstract 3
- 244000135727 Abrus pulchellus subsp cantoniensis Species 0.000 abstract 1
- 235000017112 Abrus pulchellus subsp cantoniensis Nutrition 0.000 abstract 1
- 235000013211 Adiantum capillus veneris Nutrition 0.000 abstract 1
- 241001148501 Adiantum pedatum Species 0.000 abstract 1
- 241000031023 Amana edulis Species 0.000 abstract 1
- 235000007639 Anthemis cotula Nutrition 0.000 abstract 1
- 241001647939 Ardisia crispa Species 0.000 abstract 1
- 241001407382 Berberis julianae Species 0.000 abstract 1
- 235000001553 Betula platyphylla Nutrition 0.000 abstract 1
- 241001313086 Betula platyphylla Species 0.000 abstract 1
- 244000104272 Bidens pilosa Species 0.000 abstract 1
- 235000010662 Bidens pilosa Nutrition 0.000 abstract 1
- 244000267222 Brasenia schreberi Species 0.000 abstract 1
- 235000006506 Brasenia schreberi Nutrition 0.000 abstract 1
- 241000167550 Centella Species 0.000 abstract 1
- 241000233838 Commelina Species 0.000 abstract 1
- 240000009087 Crescentia cujete Species 0.000 abstract 1
- 235000005983 Crescentia cujete Nutrition 0.000 abstract 1
- 235000005853 Cyperus esculentus Nutrition 0.000 abstract 1
- 244000285774 Cyperus esculentus Species 0.000 abstract 1
- 241000332747 Dysosma versipellis Species 0.000 abstract 1
- 240000003218 Eryngium foetidum Species 0.000 abstract 1
- 235000010283 Eryngium foetidum Nutrition 0.000 abstract 1
- 241000221079 Euphorbia <genus> Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 235000013717 Houttuynia Nutrition 0.000 abstract 1
- 240000000691 Houttuynia cordata Species 0.000 abstract 1
- 244000219416 Hypericum japonicum Species 0.000 abstract 1
- 241001517093 Iris lactea Species 0.000 abstract 1
- 235000009797 Lagenaria vulgaris Nutrition 0.000 abstract 1
- 244000297531 Lespedeza cuneata Species 0.000 abstract 1
- 241000219991 Lythraceae Species 0.000 abstract 1
- 244000179560 Prunella vulgaris Species 0.000 abstract 1
- 241000219784 Sophora Species 0.000 abstract 1
- 240000007267 Stephania hernandifolia Species 0.000 abstract 1
- 235000003595 Tagetes minuta Nutrition 0.000 abstract 1
- 235000008214 Thlaspi arvense Nutrition 0.000 abstract 1
- 235000007212 Verbena X moechina Moldenke Nutrition 0.000 abstract 1
- 240000001519 Verbena officinalis Species 0.000 abstract 1
- 235000001594 Verbena polystachya Kunth Nutrition 0.000 abstract 1
- 235000007200 Verbena x perriana Moldenke Nutrition 0.000 abstract 1
- 235000002270 Verbena x stuprosa Moldenke Nutrition 0.000 abstract 1
- 230000007547 defect Effects 0.000 abstract 1
- 238000002651 drug therapy Methods 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 32
- 239000008280 blood Substances 0.000 description 32
- 231100000614 poison Toxicity 0.000 description 32
- 230000001737 promoting effect Effects 0.000 description 30
- 239000003440 toxic substance Substances 0.000 description 30
- 210000004185 liver Anatomy 0.000 description 28
- 208000004880 Polyuria Diseases 0.000 description 26
- 230000035619 diuresis Effects 0.000 description 26
- 210000004072 lung Anatomy 0.000 description 25
- 210000000952 spleen Anatomy 0.000 description 19
- 210000003734 kidney Anatomy 0.000 description 17
- 210000002784 stomach Anatomy 0.000 description 16
- 206010030113 Oedema Diseases 0.000 description 15
- 208000002193 Pain Diseases 0.000 description 15
- 235000009508 confectionery Nutrition 0.000 description 15
- 210000002429 large intestine Anatomy 0.000 description 15
- 230000001939 inductive effect Effects 0.000 description 13
- 206010020751 Hypersensitivity Diseases 0.000 description 12
- 230000007815 allergy Effects 0.000 description 12
- 229940079593 drug Drugs 0.000 description 12
- 238000001816 cooling Methods 0.000 description 11
- 210000002216 heart Anatomy 0.000 description 11
- 208000026935 allergic disease Diseases 0.000 description 10
- 210000000232 gallbladder Anatomy 0.000 description 8
- 230000023597 hemostasis Effects 0.000 description 8
- 241000594558 Labium Species 0.000 description 6
- 229930182555 Penicillin Natural products 0.000 description 6
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 6
- 238000010255 intramuscular injection Methods 0.000 description 6
- 239000007927 intramuscular injection Substances 0.000 description 6
- 229940049954 penicillin Drugs 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 5
- 206010062717 Increased upper airway secretion Diseases 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 5
- 210000004907 gland Anatomy 0.000 description 5
- 208000026435 phlegm Diseases 0.000 description 5
- 210000003905 vulva Anatomy 0.000 description 5
- 206010010774 Constipation Diseases 0.000 description 4
- 206010037660 Pyrexia Diseases 0.000 description 4
- 208000033809 Suppuration Diseases 0.000 description 4
- 208000003455 anaphylaxis Diseases 0.000 description 4
- 230000003628 erosive effect Effects 0.000 description 4
- 230000002496 gastric effect Effects 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 231100000252 nontoxic Toxicity 0.000 description 4
- 230000003000 nontoxic effect Effects 0.000 description 4
- 210000003932 urinary bladder Anatomy 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 3
- 241000721047 Danaus plexippus Species 0.000 description 3
- 241001313288 Labia Species 0.000 description 3
- 208000007502 anemia Diseases 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 230000003908 liver function Effects 0.000 description 3
- 201000004792 malaria Diseases 0.000 description 3
- 210000004877 mucosa Anatomy 0.000 description 3
- 238000010926 purge Methods 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 206010002198 Anaphylactic reaction Diseases 0.000 description 2
- 206010002199 Anaphylactic shock Diseases 0.000 description 2
- 206010009657 Clostridium difficile colitis Diseases 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 208000003100 Pseudomembranous Enterocolitis Diseases 0.000 description 2
- 206010037128 Pseudomembranous colitis Diseases 0.000 description 2
- 208000001647 Renal Insufficiency Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 102000003929 Transaminases Human genes 0.000 description 2
- 108090000340 Transaminases Proteins 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000036783 anaphylactic response Effects 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 210000000860 cochlear nerve Anatomy 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000000762 glandular Effects 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 201000006370 kidney failure Diseases 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 208000035824 paresthesia Diseases 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 210000002640 perineum Anatomy 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 210000001732 sebaceous gland Anatomy 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 210000000106 sweat gland Anatomy 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 201000005060 thrombophlebitis Diseases 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 230000001720 vestibular Effects 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 201000010000 Agranulocytosis Diseases 0.000 description 1
- 206010001580 Albuminuria Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010049244 Ankyloglossia congenital Diseases 0.000 description 1
- WZPBZJONDBGPKJ-UHFFFAOYSA-N Antibiotic SQ 26917 Natural products O=C1N(S(O)(=O)=O)C(C)C1NC(=O)C(=NOC(C)(C)C(O)=O)C1=CSC(N)=N1 WZPBZJONDBGPKJ-UHFFFAOYSA-N 0.000 description 1
- 201000003126 Anuria Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241000255791 Bombyx Species 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- 241001115458 Carphophis Species 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010011509 Crystalluria Diseases 0.000 description 1
- 206010011894 Deafness permanent Diseases 0.000 description 1
- 208000006313 Delayed Hypersensitivity Diseases 0.000 description 1
- 206010013886 Dysaesthesia Diseases 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 206010014950 Eosinophilia Diseases 0.000 description 1
- 206010053155 Epigastric discomfort Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- DNYGXMICFMACRA-XHEDQWPISA-N Gentamicin C2b Chemical compound O1[C@H](CNC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N DNYGXMICFMACRA-XHEDQWPISA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010018687 Granulocytopenia Diseases 0.000 description 1
- 206010018852 Haematoma Diseases 0.000 description 1
- 208000032139 Halitosis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010023129 Jaundice cholestatic Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 241000237536 Mytilus edulis Species 0.000 description 1
- 206010029155 Nephropathy toxic Diseases 0.000 description 1
- 201000005267 Obstructive Jaundice Diseases 0.000 description 1
- 206010033661 Pancytopenia Diseases 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 102100027378 Prothrombin Human genes 0.000 description 1
- 108010094028 Prothrombin Proteins 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010037423 Pulmonary oedema Diseases 0.000 description 1
- 241000270295 Serpentes Species 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 206010042170 Strangury Diseases 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 229960004821 amikacin Drugs 0.000 description 1
- LKCWBDHBTVXHDL-RMDFUYIESA-N amikacin Chemical compound O([C@@H]1[C@@H](N)C[C@H]([C@@H]([C@H]1O)O[C@@H]1[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O1)O)NC(=O)[C@@H](O)CCN)[C@H]1O[C@H](CN)[C@@H](O)[C@H](O)[C@H]1O LKCWBDHBTVXHDL-RMDFUYIESA-N 0.000 description 1
- 229960003022 amoxicillin Drugs 0.000 description 1
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 230000002052 anaphylactic effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 239000000729 antidote Substances 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- WZPBZJONDBGPKJ-VEHQQRBSSA-N aztreonam Chemical compound O=C1N(S([O-])(=O)=O)[C@@H](C)[C@@H]1NC(=O)C(=N/OC(C)(C)C(O)=O)\C1=CSC([NH3+])=N1 WZPBZJONDBGPKJ-VEHQQRBSSA-N 0.000 description 1
- 229960003644 aztreonam Drugs 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 238000005282 brightening Methods 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 229960003669 carbenicillin Drugs 0.000 description 1
- FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 description 1
- 229960004682 cefoperazone Drugs 0.000 description 1
- GCFBRXLSHGKWDP-XCGNWRKASA-N cefoperazone Chemical compound O=C1C(=O)N(CC)CCN1C(=O)N[C@H](C=1C=CC(O)=CC=1)C(=O)N[C@@H]1C(=O)N2C(C(O)=O)=C(CSC=3N(N=NN=3)C)CS[C@@H]21 GCFBRXLSHGKWDP-XCGNWRKASA-N 0.000 description 1
- 229960004261 cefotaxime Drugs 0.000 description 1
- GPRBEKHLDVQUJE-VINNURBNSA-N cefotaxime Chemical compound N([C@@H]1C(N2C(=C(COC(C)=O)CS[C@@H]21)C(O)=O)=O)C(=O)/C(=N/OC)C1=CSC(N)=N1 GPRBEKHLDVQUJE-VINNURBNSA-N 0.000 description 1
- 229960000484 ceftazidime Drugs 0.000 description 1
- NMVPEQXCMGEDNH-TZVUEUGBSA-N ceftazidime pentahydrate Chemical compound O.O.O.O.O.S([C@@H]1[C@@H](C(N1C=1C([O-])=O)=O)NC(=O)\C(=N/OC(C)(C)C(O)=O)C=2N=C(N)SC=2)CC=1C[N+]1=CC=CC=C1 NMVPEQXCMGEDNH-TZVUEUGBSA-N 0.000 description 1
- 229960001991 ceftizoxime Drugs 0.000 description 1
- NNULBSISHYWZJU-LLKWHZGFSA-N ceftizoxime Chemical compound N([C@@H]1C(N2C(=CCS[C@@H]21)C(O)=O)=O)C(=O)\C(=N/OC)C1=CSC(N)=N1 NNULBSISHYWZJU-LLKWHZGFSA-N 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 229940038649 clavulanate potassium Drugs 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 239000011094 fiberboard Substances 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- DNYGXMICFMACRA-UHFFFAOYSA-N gentamicin C1A Natural products O1C(CNC)CCC(N)C1OC1C(O)C(OC2C(C(NC)C(C)(O)CO2)O)C(N)CC1N DNYGXMICFMACRA-UHFFFAOYSA-N 0.000 description 1
- 150000002333 glycines Chemical class 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 210000001144 hymen Anatomy 0.000 description 1
- 230000036543 hypotension Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000011221 initial treatment Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229960004744 micronomicin Drugs 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 235000020638 mussel Nutrition 0.000 description 1
- 230000007694 nephrotoxicity Effects 0.000 description 1
- 231100000417 nephrotoxicity Toxicity 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 229940041024 other aminoglycosides in atc Drugs 0.000 description 1
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 208000001297 phlebitis Diseases 0.000 description 1
- 229960002292 piperacillin Drugs 0.000 description 1
- IVBHGBMCVLDMKU-GXNBUGAJSA-N piperacillin Chemical compound O=C1C(=O)N(CC)CCN1C(=O)N[C@H](C=1C=CC=CC=1)C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 IVBHGBMCVLDMKU-GXNBUGAJSA-N 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- ABVRVIZBZKUTMK-JSYANWSFSA-M potassium clavulanate Chemical compound [K+].[O-]C(=O)[C@H]1C(=C/CO)/O[C@@H]2CC(=O)N21 ABVRVIZBZKUTMK-JSYANWSFSA-M 0.000 description 1
- ZRHANBBTXQZFSP-UHFFFAOYSA-M potassium;4-amino-3,5,6-trichloropyridine-2-carboxylate Chemical compound [K+].NC1=C(Cl)C(Cl)=NC(C([O-])=O)=C1Cl ZRHANBBTXQZFSP-UHFFFAOYSA-M 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 229940039716 prothrombin Drugs 0.000 description 1
- 208000005333 pulmonary edema Diseases 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 239000011435 rock Substances 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 239000003998 snake venom Substances 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 229960005404 sulfamethoxazole Drugs 0.000 description 1
- JLKIGFTWXXRPMT-UHFFFAOYSA-N sulphamethoxazole Chemical compound O1C(C)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 JLKIGFTWXXRPMT-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 229960004659 ticarcillin Drugs 0.000 description 1
- OHKOGUYZJXTSFX-KZFFXBSXSA-N ticarcillin Chemical compound C=1([C@@H](C(O)=O)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)C=CSC=1 OHKOGUYZJXTSFX-KZFFXBSXSA-N 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 230000036228 toxication Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 208000002003 vulvitis Diseases 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
一种治疗肿胀型前庭大腺炎的中药洗剂制备方法,属于中药制备方法技术领域。目前治疗肿胀型前庭大腺炎,一般采用西药治疗,其缺点是毒副作用大。该发明的技术方案为:取八角莲、三颗针、大金钱草、山豆根、山海螺、山慈姑、千金藤、小飞扬草、马蔺子、马鞭草、地耳草、百两金、过坛龙、连翘、针砂、鸡骨草、知母、鱼腥草、夜关门、夜明砂、鬼针草、穿心莲、桦木皮、壶卢、荸荠、莼、夏枯草、鸭跖草、积雪草、臭草、葎草和甘草等,将以上中药放入水中浸泡,然后文火煎制,过滤去渣,煎出的药液即为治疗肿胀型前庭大腺炎的中药洗剂。它的优点是:制成的中药液毒副作用小,疗程短,治愈率高。君臣佐使,恰到好处。
Description
技术领域
本发明涉及中药洗剂制备方法技术领域,更具体的讲是一种治疗肿胀型前庭大腺炎的中药洗剂制备方法。
背景技术
目前治疗肿胀型前庭大腺炎,一般采用:
1、头孢他啶:①肌注局部有疼痛;②偶可发生皮疹等变态反应;③肾功能不全或无尿患者宜减量或暂停。
2、阿莫西林:偶见皮疹,口服大量后可有恶心、上腹部不适、腹泻等;伪膜性结肠炎。
3、羧苄西林:可以出现各种类型的变态反应。大剂量给药后可能引起神经毒反应、肺水肿,用药期间可能出现短暂性转氨酶升高与粒细胞减少。
4、氨苄西林:大量口服常出现胃肠道不适。肌注局部有疼痛。无论口服或注射均可引起变态反应,以皮疹为多见。用药前必须先做皮试。
5、哌拉西林:肌注后偶有局部疼痛,快速静脉推注可导致暂时性恶心、胸闷、咳嗽、发热、口腔异味、眼结膜充血,变态反应(皮疹、痒感、头晕、麻木、发热等),用药前必须注意青霉素有无过敏史,并做青霉素皮试。
6、头孢噻肟:肌注局部可有疼痛;静注时可有血栓性静脉炎发生;皮疹、药物热等变态反应。
7、青霉素:本品易发生变态反应,特别是过敏性休克(最危险的过敏性休克,可发生在做皮肤试验的当时,极少数可发生在连续用药过程中,迟发性过敏性休克),如不及时抢救,可危急生命,故用药前、中、后都要提高防护,以免发生意外。注意:应用前,必须问清有无过敏性疾病,用青霉素后有无皮疹、发热等变态反应出现,务必先做青霉素皮试。
8、氨曲南:偶有味觉异常、皮疹、轻度胃肠道反应,肌注局部疼痛,静注可出现静脉炎。
9、卡那霉素:本品对听神经和肾脏均有毒性,前者表现为耳鸣、听力减退、甚至永久性耳聋(因以前庭损害为主,故比较严重),为此对老年人、孕妇(可影响胎儿)必须高度警惕为孕;后者表现为蛋白尿、管型尿等。
10、采用磺胺甲恶唑患者有时引起胃肠道反应、结晶尿、血尿、皮疹、药热及白细胞减少。
11、头孢哌酮:肌注局部可有疼痛;偶见皮疹、药物热等变态反应;个别病人可出现全血细胞减少、一过性转氨酶升高、凝血酶原时间延长或出血等。
12、替卡西林钠克拉维酸钾:①过敏反应参见“青霉素”。②可见恶心、呕吐和腹泻等胃肠道反应以及肝脏功能改变AST或ALT增高,假膜性结肠炎罕见,个别报道可出现肝炎和胆汁淤积性黄疸。③肾功能不全或大剂量用本品有出现惊厥的报道。④局部静脉注射部位的血栓性静脉炎。
13、头孢唑肟:①本品偶可致过敏,对可疑过敏病人特加防护;②用药期间可能出现胃肠道反应、肝功能改变、尿素氮增高、红细胞与血色素减少等。
14、阿米卡星:肾毒性与耳毒症状必然存在。偶有恶心、呕吐、头痛、发热、皮疹、震颤、感觉异常、关节疼痛、嗜酸粒细胞增多、贫血及低血压等。
15、小诺米星:①长期大量应用,可能引起听神经和肾脏毒害;②少数病人可出现皮疹等变态反应,对其他氨基糖甙类抗生素有过敏史者忌用;③肾功能减退及老年人慎用;④肝功能异常及孕妇慎用。
发明内容
为克服上述缺点,本发明的目的是发明一种治疗肿胀型前庭大腺炎的中药洗剂制备方法。大阴唇:为两股内侧的皮肤皱襞,左右各一。前接阴阜,两相会合形成阴唇前联合;后达会阴,两侧合成阴唇后联合。大阴唇分为内外两侧面:外侧面有阴毛、汗腺及皮脂腺;内侧面湿润似粘膜。大阴唇皮下富有脂肪组织、弹性纤维板及静脉丛,若受伤,易出血,形成血肿。小阴唇:位于大阴唇内侧,为类似鸡冠状的皮肤皱襞,酷似粘膜,左右各一,围绕阴道前庭。在大阴唇中、下1/3交界处,大小阴唇连成一片,左右两片又在正中线会合而成为一条横皱襞,称为阴唇系带。小阴唇内有较多皮脂腺与少数汗腺,神经末梢丰富,甚为敏感。前庭大腺:左右各一,位于大阴唇深部,约似黄豆大,腺管长且细,开口于小阴唇和处女膜之间的沟内,相当于阴道外口中、下1/3处。能分泌黄白色液体,以滑润阴道口。定义:前庭大腺炎是指前庭大腺侵入病原体如链球菌、葡萄球菌、大肠杆菌及霉菌、滴虫等通过粘膜蔓延、经血行散布、经淋巴扩散,直接蔓延等多种途径,引起的炎症。祖国医学记载:妇人阴户肿痛,甚或化脓溃疡,黄水淋沥;或阴户一侧凝结成块坚硬,或如蚕茧状者,总称“阴疮”,包括“阴肿”、“蚌疽”、“阴茧”、“阴蚀”等。阴疮,首见于《金匮要略》:“少阴脉滑而数者,阴中即生疮”,“阴中蚀疮烂者,狼牙汤洗之”。
病因病机:湿热蕴结,毒邪入侵会阴部,毒热互结,而发本病。
临床表现:会阴部肿胀,行走时加重,疼痛。急性期腺体常肿胀变大,产生大量脓性分泌物。腺管口红肿外翻,挤压腺体可有脓性分泌物流出。重者同侧小阴唇亦红肿,终至整个腺体成为肿胀,局部压痛,行路困难,并出现体温及白细胞增高等周身症状。口干、大便秘结、小便涩滞,舌红,苔黄,脉数。
它的技术方案为:取八角莲6重量份、三颗针6重量份、大金钱草6重量份、山豆根6重量份、山海螺5重量份、山慈姑6重量份、千金藤5重量份、小飞扬草6重量份、马蔺子6重量份、马鞭草6重量份、地耳草6重量份、百两金6重量份、过坛龙4重量份、连翘6重量份、针砂5重量份、鸡骨草6重量份、知母6重量份、鱼腥草6重量份、夜关门6重量份、夜明砂2重量份、鬼针草6重量份、穿心莲6重量份、桦木皮3重量份、壶卢6重量份、荸荠6重量份、莼6重量份、夏枯草6重量份、鸭跖草2重量份、积雪草6重量份、臭草6重量份、拳参2重量份、栀子6重量份、救必应5重量份、野菊花6重量份、象皮木6重量份、葎草6重量份和甘草9重量份,将以上37味中药放入1800毫升水中,浸泡30分钟,然后文火煎制30分钟,过滤去渣共煎药液390毫升,煎出的药液即为治疗肿胀型前庭大腺炎的中药洗剂。
该发明的优点是:本方37味中药,在药店均能买到,制作简单,制成的中药液毒副作用小,疗程短,治愈率高。君臣佐使,恰到好处。应用中药的同时,避免了西药抗菌素引起的不良反应、过敏反应和毒性反应。八角莲、三颗针、大金钱草、山豆根、山海螺、山慈姑、千金藤、小飞扬草、马蔺子、马鞭草、地耳草、百两金、过坛龙、连翘、针砂、鸡骨草、知母、鱼腥草、夜关门、夜明砂,以上20味药具有养阴清热,清热解毒,祛瘀消肿,益肾防劳,清热利湿,活血散瘀,解毒消肿,消毒散结,止咳化痰,泻下通便,祛风除痹,利水消肿,解毒疗疮,消积化痞,疏风解表,凉血止血,排脓生肌,清肝明目,健脾和胃,杀虫止痒之功效。在治疗肿胀型前庭大腺炎的过程中,起主要治疗作用,故为君药。鬼针草、穿心莲、桦木皮、壶卢、荸荠、莼、夏枯草、鸭跖草、积雪草、臭草、拳参、栀子、救必应、野菊花、象皮木,以上15味药具有清热凉血,活血消瘀,祛瘀止痛,行血通络,凉血解毒之功效。在治疗肿胀型前庭大腺炎的过程中,能辅助主药发挥治疗作用,故为臣药。葎草:甘、苦,寒,无毒。入肺、肾、大肠三经。清热解毒,利尿消肿,消瘀散结。能率诸药直达病灶,故为佐药。甘草:甘,平。入十二经。补脾润肺,益气复脉,缓急止痛,清热解毒,调和药性。既能纠诸药之偏性,又能缓解诸药之毒性,故为使药。八角莲、三颗针、大金钱草、山豆根、山海螺、山慈姑、千金藤、小飞扬草、马蔺子、马鞭草、地耳草、百两金、过坛龙、连翘、针砂、鸡骨草、知母、鱼腥草、夜关门、夜明砂、鬼针草、穿心莲、桦木皮、壶卢、荸荠、莼、夏枯草、鸭跖草、积雪草、臭草、拳参、栀子、救必应、野菊花、象皮木、葎草、甘草,这37味药配伍应用,共同起到清热解毒、利水消肿,消肿止痛,凉血止血,行瘀排脓,清热凉血,活血消瘀,行血通络之功效。君臣佐使,配伍得当,是治疗肿胀型前庭大腺炎的最佳配方。八角莲:苦、辛,平。入心、肺、肾三经。清热解毒,祛瘀消肿,止咳化痰,益肾防劳。三颗针:苦、寒,无毒。入肝、胃、大肠三经。清热利湿,清肝明目,散瘀消肿。大金钱草:甘、咸,微寒。入肝、胆、肾、膀胱四经。清热利湿,和胃降逆,解毒消肿,祛瘀消肿。山豆根:苦,寒。入心、肺、大肠三经。清热解毒,消肿止痛。山海螺:甘、辛,平。入肺、大肠、肝二经。排脓生肌,解毒消肿,祛痰散结,催发乳汁。山慈姑:甘、微辛,寒。入肝、脾、肺三经。解毒消肿,散结化痰。千金藤:苦,寒。入肺、脾、大肠三经。清热解毒,利尿消肿,祛风活络。小飞扬草:酸、涩、苦,凉。入脾、胃、大肠三经。清热利湿,解毒消肿。马蔺子:甘,平。入脾、胃、肺三经。清热利湿,解毒消肿,凉血止血,祛湿通痹,健脾和胃。马鞭草:苦、辛,寒。入肝、脾二经。清热解毒,活血散瘀,利水消肿,截疟。地耳草:甘、苦,寒。入肝、胆、脾、胃、大肠五经。清热利湿,解毒消肿,散瘀止痛。百两金:苦、辛,凉。入肺、胃、肝、胆、大肠、肾六经。清热利湿,祛痰止咳,利尿消肿。过坛龙:苦、辛,凉。入胃、肝、胆、膀胱、大肠五经。清热利湿,凉血止血,消瘀散肿。连翘:苦,凉。入心、肝、胆三经。清热解毒,消肿散结,清热利尿,白虫病,经闭,疹子。针砂:酸、辛,平。入脾、大肠二经。清热利湿,消滞散结,黄胖病。鸡骨草:甘,凉。入肝、脾、胃、肾四经。清热解毒,舒肝和脾,散瘀止痛,软坚散结,疗毒蛇伤。知母:苦,寒。入肺、胃、肾三经。清热泻火,滋阴润燥,滑肠通便,利水消肿。鱼腥草:辛,寒。入肝、肺二经。清热解毒,解毒消痈,利尿消肿。夜关门:苦、辛,凉。入肺、肝、肾三经。补益肝肾,止咳平喘,消肿散瘀,益肝明目。夜明砂:辛、微苦,寒。入心、肝、脾三经。清肝明目,散血消积, 安神止惊,软坚散结,截疟。鬼针草:苦,平,无毒。入肺、胃、大肠、胆四经。散瘀消肿,截疟退热,止泻除痢,清热退黄,清热消肿,解虫蛇毒。穿心莲:苦,寒。入心、肺二经。清热解毒,清化湿热,凉血消肿,解蛇毒。桦木皮:苦,寒。入肺、胃二经。清热燥湿,解毒消痈,肺风毒疮,祛痰平喘,染发黑须。壶卢:甘,淡,平。入肺、脾、肾三经。利尿消肿,清热通淋,岩肿恶疮。荸荠:甘,寒。入肺、胃、心、肝四经。清热凉血,滋阴生津,消食散结。莼:甘、微苦,寒。入肝、脾、胃三经。清热解毒,清热利痹,生津止渴,利水消肿,润肠通便。夏枯草:苦、辛,寒。入肝、胆、脾三经。清肝泻火,清热散结。鸭跖草:甘,寒。入心、肝、胆、脾、大肠五经。清热解毒,清热利湿,利尿消肿,凉血止血。积雪草:苦、辛,寒。入心、肺、脾、肝、肾五经。清热利湿,清热泻火,消肿解毒,凉血止血,祛风化毒,软坚散结。臭草:苦、辛,寒。入肺、肾、肝、心四经。祛风退热,清热解毒,利水消肿,活血化瘀,凉血止血,行气渗湿。拳参:苦,微寒。入心、大肠、膀胱三经。泻热利湿止痢,清热解毒消肿,清热镇惊。栀子:苦,寒。入心、肝、肺、胃、肾、膀胱六经。清透郁热,泻热利湿,凉血止血,消肿止痛,清热解毒。救必应:苦,寒。入肺、肝、大肠三经。清热解毒,清热燥湿,消肿止痛。野菊花:苦、甘、辛,凉。入肺、二肝经。疏风清热,解毒消肿,疏肝破血。象皮木:苦、淡,寒。入肺、肝二经。清热解毒,止血消肿。葎草:甘、苦,寒,无毒。入肺、肾、大肠三经。清热解毒,利尿消肿,消瘀散结。甘草:甘,平。入十二经。补脾润肺,益气复脉,缓急止痛,清热解毒,调和药性。
具体实施方式:取八角莲6g、三颗针6g、大金钱草6g、山豆根6g、山海螺5g、山慈姑6g、千金藤5g、小飞扬草6g、马蔺子6g、马鞭草6g、地耳草6g、百两金6g、过坛龙4g、连翘6g、针砂5g、鸡骨草6g、知母6g、鱼腥草6g、夜关门6g、夜明砂2g、鬼针草6g、穿心莲6g、桦木皮3g、壶卢6g、荸荠6g、莼6g、夏枯草6g、鸭跖草2g、积雪草6g、臭草6g、拳参2g、栀子6g、救必应5g、野菊花6g、象皮木6g、葎草6g和甘草9g,将以上37味药一起放入1800毫升水中,浸泡30分钟,然后文火煎制30分钟,过滤去渣,煎出的药液即为治疗肿胀型前庭大腺炎的中药洗剂。共煎药液390毫升,当肿胀型前庭大腺炎的病人需要治疗时,使药液温度为35℃,每次130毫升,擦洗患处,每日三次, 二日为一疗程,若症状仍存,再洗第二疗程,以至痊愈。
肿胀型前庭大腺炎患者共386例.
表一、386例肿胀型前庭大腺炎患者的年龄范围
年龄(岁) | 21~25 | 26~30 | 31~35 | 36~40 |
例数 | 26 | 206 | 139 | 15 |
百分比 | 6.7% | 53.4% | 36% | 3.9% |
表二、386例肿胀型前庭大腺炎患者疗效表
疗效 | 治愈 | 好转 | 无效 |
例数 | 383 | 3 | 无 |
百分比 | 99.2% | 0.8% | 无 |
表三、386例肿胀型前庭大腺炎患者疗程表
治疗天数 | 3~5 | 6~9 | 10~14 | 15~21 |
例数 | 32 | 196 | 151 | 7 |
百分比 | 8.3% | 50.8% | 39.1% | 1.8% |
表四、386例肿胀型前庭大腺炎患者治疗前后情况表
Claims (1)
1.一种治疗肿胀型前庭大腺炎的中药洗剂制备方法,其特征是:取八角莲6克、三颗针6克、大金钱草6克、山豆根6克、山海螺5克、山慈姑6克、千金藤5克、小飞扬草6克、马蔺子6克、马鞭草6克、地耳草6克、百两金6克、过坛龙4克、连翘6克、针砂5克、鸡骨草6克、知母6克、鱼腥草6克、夜关门6克、夜明砂2克、鬼针草6克、穿心莲6克、桦木皮3克、壶卢6克、荸荠6克、莼6克、夏枯草6克、鸭跖草2克、积雪草6克、臭草6克、拳参2克、栀子6克、救必应5克、野菊花6克、象皮木6克、葎草6克和甘草9克,将以上37味中药放入1800毫升水中,浸泡30分钟,然后文火煎制30分钟,过滤去渣共煎药液390毫升,煎出的药液即为治疗肿胀型前庭大腺炎的中药洗剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310458861XA CN103463445A (zh) | 2013-10-07 | 2013-10-07 | 一种治疗肿胀型前庭大腺炎的中药洗剂制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310458861XA CN103463445A (zh) | 2013-10-07 | 2013-10-07 | 一种治疗肿胀型前庭大腺炎的中药洗剂制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103463445A true CN103463445A (zh) | 2013-12-25 |
Family
ID=49788637
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310458861XA Pending CN103463445A (zh) | 2013-10-07 | 2013-10-07 | 一种治疗肿胀型前庭大腺炎的中药洗剂制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103463445A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103751498A (zh) * | 2014-01-05 | 2014-04-30 | 张波 | 一种治疗嗜食烤猪肉型高脂血症的中药制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4258037A (en) * | 1976-12-02 | 1981-03-24 | Sertog Societe D'etudes De Recherches De Travoux D'organisation Et De Gestion | Therapeutic compounds for the treatment of uro-genital disorders |
CN103230536A (zh) * | 2013-05-25 | 2013-08-07 | 顾克峰 | 一种治疗嗜饮热茶型贲门炎的中药制备方法 |
CN103230521A (zh) * | 2013-04-30 | 2013-08-07 | 李静 | 一种治疗肿胀型脓性指头炎的中药洗剂制备方法 |
-
2013
- 2013-10-07 CN CN201310458861XA patent/CN103463445A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4258037A (en) * | 1976-12-02 | 1981-03-24 | Sertog Societe D'etudes De Recherches De Travoux D'organisation Et De Gestion | Therapeutic compounds for the treatment of uro-genital disorders |
CN103230521A (zh) * | 2013-04-30 | 2013-08-07 | 李静 | 一种治疗肿胀型脓性指头炎的中药洗剂制备方法 |
CN103230536A (zh) * | 2013-05-25 | 2013-08-07 | 顾克峰 | 一种治疗嗜饮热茶型贲门炎的中药制备方法 |
Non-Patent Citations (3)
Title |
---|
冉先德: "《中华药海 上册》", 31 August 1993, article "清热药", pages: 1-2 * |
张文义等: "《中医临床荟萃》", 30 June 2008, article "十一、贲门肿胀", pages: 410 * |
李元文等: "《中医性学》", 31 January 2013, article "第二节 前庭大腺炎", pages: 401-402 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103751498A (zh) * | 2014-01-05 | 2014-04-30 | 张波 | 一种治疗嗜食烤猪肉型高脂血症的中药制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103463508A (zh) | 一种治疗过食烤鱼型前庭大腺炎的中药洗剂制备方法 | |
CN103463447A (zh) | 一种治疗目赤型前庭大腺炎的中药洗剂制备方法 | |
CN103479885A (zh) | 一种治疗溲赤型前庭大腺炎的中药洗剂制备方法 | |
CN103446487A (zh) | 一种治疗过食干姜型前庭大腺炎的中药洗剂制备方法 | |
CN103446359A (zh) | 一种治疗过食肥肉型前庭大腺炎的中药洗剂制备方法 | |
CN103463504A (zh) | 一种治疗咳嗽型前庭大腺炎的中药洗剂制备方法 | |
CN103463445A (zh) | 一种治疗肿胀型前庭大腺炎的中药洗剂制备方法 | |
CN103446353A (zh) | 一种治疗过食川椒型前庭大腺炎的中药洗剂制备方法 | |
CN103463328A (zh) | 一种治疗嗜食猪肝型前庭大腺炎的中药洗剂制备方法 | |
CN103479925A (zh) | 一种治疗痰火内扰型前庭大腺炎的中药洗剂制备方法 | |
CN103446448A (zh) | 一种治疗搔痒型前庭大腺炎的中药洗剂制备方法 | |
CN103446447A (zh) | 一种治疗嗜食酸菜型前庭大腺炎的中药洗剂制备方法 | |
CN103463353A (zh) | 一种治疗出血型前庭大腺炎的中药洗剂制备方法 | |
CN103463507A (zh) | 一种治疗嗜食大蒜型前庭大腺炎的中药洗剂制备方法 | |
CN103463319A (zh) | 一种治疗嗜食鲜姜型前庭大腺炎的中药洗剂制备方法 | |
CN103446446A (zh) | 一种治疗热毒型前庭大腺炎的中药洗剂制备方法 | |
CN103479834A (zh) | 一种治疗肿块型前庭大腺炎的中药洗剂制备方法 | |
CN103495034A (zh) | 一种治疗火毒郁结型前庭大腺炎的中药洗剂制备方法 | |
CN103463446A (zh) | 一种治疗口舌生疮型前庭大腺炎的中药洗剂制备方法 | |
CN103463330A (zh) | 一种治疗发热型前庭大腺炎的中药洗剂制备方法 | |
CN103494970A (zh) | 一种治疗肝胆湿热型前庭大腺炎的中药洗剂制备方法 | |
CN103463505A (zh) | 一种治疗便秘型前庭大腺炎的中药洗剂制备方法 | |
CN103479922A (zh) | 一种治疗嗜食油炸食品型前庭大腺炎的中药洗剂制备方法 | |
CN103479808A (zh) | 一种治疗疼痛型前庭大腺炎的中药洗剂制备方法 | |
CN103495033A (zh) | 一种治疗过食高热食品型前庭大腺炎的中药洗剂制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C12 | Rejection of a patent application after its publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20131225 |